UP!
| Type of business | Public |
|---|---|
| Traded as | NASDAQ: LPSN S&P 600 Component TASE: LPSN |
| Founded | 1995 (1995) |
| Headquarters | New York City |
| No. of locations | London, Berlin, Paris, Tel Aviv, San Francisco, Atlanta, Tokyo, Melbourne, Mannheim, Amsterdam, Milan |
| Area served | Worldwide |
| Key people | Robert LoCascio, CEO |
| Industry | Internet Computer software |
| Products | LiveEngage LP Insights |
| Revenue |  US$ 209.93 million (2014) |
| Employees | 1,058 (As of December 2014) |
| Subsidiaries | LivePerson Ltd. (formerly HumanClick Ltd.) Kasamba Inc. Presto Experts Contact At Once!, LLC Engage Pty Ltd. LivePerson (UK) Ltd. LivePerson Netherlands B.V |
| Slogan(s) | We Make Meaningful Connections |
| Website | liveperson.com |
LivePerson is a publicly held American technology company that develops products for online messaging, marketing, and analytics.
Headquartered in New York City, LivePerson is best known as the developer of LiveEngage- a messaging platform that allows companies to talk with visitors in real time on websites, mobile, and social networks.
LivePerson was founded in 1995 by Robert LoCascio after a disastrous customer service experience online. In April 2000, the company completed an initial public offering on the NASDAQ, in March 2011 its shares started trading also on the Tel Aviv Stock Exchange and are included in the TA-100 Index and the TA BlueTech Index.
Since its founding, LivePerson has expanded to include offices in London and Reading, England; Tel Aviv, Israel; Melbourne, Australia; Alpharetta, Georgia; Mannheim and Berlin, Germany; Amsterdam, Netherlands; Milan, Italy; Paris, France; Tokyo, Japan.
LivePerson provides a web based engagement service, also referred to as click to chat.
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-10-31 | Future report Set alerts | |
| Q2 2022 | 2022-08-08 | -0.18 | -0.18 |
| Q1 2022 | 2022-05-09 | -0.33 | -0.33 |
| Q4 2021 | 2022-02-24 | -0.22 | -0.22 |
| Q3 2021 | 2021-11-02 | -0.17 | -0.17 |
| Q2 2021 | 2021-08-03 | -0.02 | -0.02 |
| Q1 2021 | 2021-05-04 | -0.01 | -0.01 |
| Q4 2020 | 2021-02-25 | 0.09 | 0.09 |
| Q3 2020 | 2020-10-29 | 0.08 | -0.58 |
| Q2 2020 | 2020-08-04 | -0.01 | -0.28 |
| 2016-07-07 | Upgrade | Benchmark Co. | Hold to Buy | $6.00 to $9.00 |
| 2016-05-05 | Boost Price Target | Benchmark Co. | Hold | $5.00 to $6.00 |
| 2016-05-05 | Upgrade | Roth Capital | Neutral to Buy | $10.00 |
| 2016-02-11 | Boost Price Target | Northland Securities | Outperform | $7.00 to $11.00 |
| 2016-02-11 | Lower Price Target | Benchmark Co. | Hold | $8.00 to $5.00 |
| 2016-02-11 | Downgrade | Roth Capital | Buy to Neutral | $5.00 to $14.00 |
| 2016-02-11 | Reiterated Rating | Oppenheimer | Market Perform | |
| 2016-02-11 | Reiterated Rating | Oppenheimer Holdings Inc. | Market Perform | |
| 2015-11-05 | Downgrade | Craig Hallum | Buy to Hold | |
| 2015-11-05 | Lower Price Target | Benchmark Co. | Hold | $10.00 to $8.00 |
| 2015-09-08 | Initiated Coverage | Credit Suisse | Neutral | $8.00 |
| 2015-09-08 | Initiated Coverage | Credit Suisse Group AG | Neutral | $8.00 |
| 2015-05-27 | Boost Price Target | Benchmark Co. | $9.00 to $10.00 | |
| 2015-05-23 | Reiterated Rating | Craig Hallum | Buy | $13.00 to $11.00 |
| 2015-05-23 | Reiterated Rating | Benchmark Co. | Hold | $13.00 to $9.00 |
| 2015-05-23 | Downgrade | Credit Suisse | Outperform to Neutral | |
| 2015-05-22 | Reiterated Rating | Roth Capital | Buy | $23.00 to $14.00 |
| 2015-05-14 | Reiterated Rating | Craig Hallum | Buy | $13.00 to $11.00 |
| 2015-05-12 | Reiterated Rating | Oppenheimer | Market Perform | |
| 2015-05-12 | Lower Price Target | Benchmark Co. | Hold | $13.00 to $9.00 |
| 2015-05-12 | Lower Price Target | Roth Capital | Buy | $23.00 to $14.00 |
| 2015-05-12 | Downgrade | Credit Suisse | Outperform to Neutral | $21.00 to $8.00 |
| 2015-05-12 | Lower Price Target | Northland Securities | Outperform | $16.00 to $11.00 |
| 2014-10-09 | Upgrade | Credit Agricole | Neutral to Outperform | $13.00 to $17.00 |
| 2014-10-09 | Upgrade | Credit Suisse | Neutral to Outperform | $13.00 to $17.00 |
| 2014-10-09 | Upgrade | Credit Agricole SA | Neutral to Outperform | $13.00 to $17.00 |
| 2014-07-31 | Upgrade | Craig Hallum | Hold to Buy | $12.00 to $15.00 |
| 2014-07-31 | Upgrade | Credit Suisse | Underperform to Neutral | |
| 2014-05-09 | Lower Price Target | Wedbush | $14.00 to $10.00 | |
| 2014-05-08 | Lower Price Target | Maxim Group | Buy | $18.00 to $16.00 |
| 2014-04-08 | Downgrade | Benchmark Co. | Buy to Hold | $9.00 |
| 2014-02-13 | Reiterated | Northland Capital | Outperform | $15 to $16.50 |
| 2014-02-13 | Boost Price Target | Northland Securities | Outperform | $15.00 to $16.50 |
| 2014-01-21 | Boost Price Target | Maxim Group | Buy | $14.00 to $18.00 |
| 2013-12-23 | Upgrade | The Benchmark Company | Hold to Buy | $17 |
| 2013-12-23 | Upgrade | Benchmark Co. | Hold to Buy | $17.00 |
| 2013-11-07 | Boost Price Target | Wedbush | Neutral | $10.00 to $14.00 |
| 2013-10-03 | Initiated Coverage | Janney Montgomery Scott | Neutral | |
| 2013-10-01 | Lower Price Target | Benchmark Co. | Hold | $12.00 to $10.00 |
| 2013-05-09 | Reiterated | Ladenburg Thalmann | Buy | $20 to $16.25 |
| 2013-05-09 | Downgrade | Oppenheimer | Outperform to Perform | |
| 2012-11-07 | Downgrade | The Benchmark Company | Buy to Hold | $13 |
| 2012-09-12 | Initiated | The Benchmark Company | Buy | $22 |
| 2011-08-17 | Initiated | Ladenburg Thalmann | Buy | $16 |
| 2010-09-29 | Reiterated | Northland Securities | Outperform | $9.25 to $10.25 |
| 2010-02-11 | Reiterated | Broadpoint AmTech Research | Buy | $7.50 to $9 |
| 2009-10-07 | Initiated | Northland Securities | Outperform | $7 |
| 2009-10-05 | Reiterated | Roth Capital | Buy | $5 to $6 |
| 2009-09-21 | Upgrade | Broadpoint AmTech Research | Neutral to Buy | $7 |
| 2009-06-18 | Reiterated | Roth Capital | Buy | $4 to $4.50 |
| 2016-07-07 | Upgrade | Benchmark Co. | Hold to Buy | $6.00 to $9.00 |
| 2016-05-05 | Boost Price Target | Benchmark Co. | Hold | $5.00 to $6.00 |
| 2016-05-05 | Upgrade | Roth Capital | Neutral to Buy | $10.00 |
| 2016-02-11 | Boost Price Target | Northland Securities | Outperform | $7.00 to $11.00 |
| 2016-02-11 | Lower Price Target | Benchmark Co. | Hold | $8.00 to $5.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In LPSN 160 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 14.10M |
| Vanguard Group, Inc | 9.02M |
| Starboard Value LP | 7.00M |
| BlackRock Fund Advisors | 4.33M |
| MACKENZIE FINANCIAL CORP | 2.81M |
| STATE STREET CORP | 2.69M |
| HENDERSON GROUP PLC | 2.68M |
| D. E. Shaw & Co., Inc. | 1.96M |
| Discovery Group I, LLC | 1.68M |
| BlackRock Institutional Trust Company, N.A. | 1.41M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.29M |
| GRANAHAN INVESTMENT MANAGEMENT INC/MA | 1.19M |
| BAILLIE GIFFORD & CO | 1.12M |
| AWM Investment Company, Inc. | 1.03M |
| Fisher Asset Management, LLC | 0.99M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| GILL EMMANUEL | 1.35% (728454) | LPSN / |
| LOCASCIO ROBERT P Chief Executive Officer | 0.60% (321191) | LPSN / |
| BIXBY TIMOTHY E President and CFO | 0.24% (126750) | LPSN / SSTK / |
| Wesemann William | 0.22% (120000) | LPSN / |
| Vanounou Eran Chief Technology Officer | 0.20% (110000) | LPSN / |
| Murphy Daniel Richard Chief Financial Officer | 0.13% (70093) | LPSN / |
| Dean Dustin EVP, Global Sales/Cust Success | 0.13% (67487) | LPSN / |
| Greenberg Monica L. SVP, General Counsel | 0.08% (42746) | LPSN / |
| Carlough Daryl SVP, Global & Corp Controller | 0.03% (15072) | GCAP / LPSN / |
| Schultz Erica Head of Global Sales & Markets | 0.03% (15000) | LPSN / NEWR / |
| LAVAN KEVIN | 0.01% (6000) | LPSN / |
| Block Peter | 0.01% (6000) | LPSN / |
UM